JOGO Health
JOGO Health is a pioneering digital therapeutics company leveraging advanced AI, wearable sensors, and scientific research to provide non-invasive, medication-free solutions for pain, neuromuscular, and neurological disorders. Their mission is to redefine pain management and neurorehabilitation through innovative, evidence-based digital therapies that improve patient outcomes and reduce healthcare costs.
Industries
Nr. of Employees
small (1-50)
JOGO Health
991 US 22, Bridgewater Township, NJ, USA
Products
Prescription digital therapeutic platform (wearable sEMG + AI/VR mobile app)
A prescription digital therapeutic composed of wearable wireless surface EMG sensors and a patent-protected mobile application that uses AI and VR to provide adaptive therapy protocols, real-time biofeedback, and remote monitoring for neuromuscular rehabilitation and pain management.
Prescription digital therapeutic platform (wearable sEMG + AI/VR mobile app)
A prescription digital therapeutic composed of wearable wireless surface EMG sensors and a patent-protected mobile application that uses AI and VR to provide adaptive therapy protocols, real-time biofeedback, and remote monitoring for neuromuscular rehabilitation and pain management.
Services
Remote pelvic floor physical therapy combined with sEMG biofeedback delivered virtually for urinary and fecal incontinence, prolapse, pelvic pain and related conditions.
Home-delivered neurorehabilitation for stroke recovery, dystonia, spasticity and tremor reduction using wearable sEMG sensors and AI-guided therapy protocols.
Non-pharmacologic treatment programs combining EMG biofeedback and pain neuroscience education for chronic lower back pain, migraines, cancer pain and other pain conditions.
Capture of sEMG-derived digital biomarkers and remote monitoring of neuromuscular metrics to support clinical research and trial endpoints.
Operational support to help neurology and rehabilitation clinics adopt the digital therapeutic, including training and workflow integration.
Short patient intake and access to patient care coordinators via an online booking system for initial consultation and scheduling.
Remote pelvic floor physical therapy combined with sEMG biofeedback delivered virtually for urinary and fecal incontinence, prolapse, pelvic pain and related conditions.
Home-delivered neurorehabilitation for stroke recovery, dystonia, spasticity and tremor reduction using wearable sEMG sensors and AI-guided therapy protocols.
Non-pharmacologic treatment programs combining EMG biofeedback and pain neuroscience education for chronic lower back pain, migraines, cancer pain and other pain conditions.
Capture of sEMG-derived digital biomarkers and remote monitoring of neuromuscular metrics to support clinical research and trial endpoints.
Operational support to help neurology and rehabilitation clinics adopt the digital therapeutic, including training and workflow integration.
Short patient intake and access to patient care coordinators via an online booking system for initial consultation and scheduling.
Expertise Areas
- Digital neurology and neurorehabilitation
- EMG biofeedback therapy
- Chronic pain management using non-pharmacologic interventions
- Pelvic floor rehabilitation delivered virtually
Key Technologies
- Surface electromyography (sEMG)
- Wearable wireless sensors
- AI-driven analytics
- Mobile health applications
News & Updates
Case study of digital therapeutics (JOGO) for post right MCA infarction, presented in December 2019.
Case study of utilization of digital therapeutics (JOGO) for post right MCA infarction.
A scientific publication in Nature Nov 2019 demonstrating the impact of EMG biofeedback on muscle activity in elderly adults.
A pilot randomized clinical trial published in Digital Health Jan 2023 showing the efficacy of JOGO's EMG biofeedback in chronic pain.
FDA Clearance and Reimbursement
JOGO's digital therapeutics are FDA-cleared and reimbursed by Medicare and commercial insurance for various conditions including cancer pain, migraines, pelvic pain, stroke recovery, and neuromuscular disorders.
Scientific Validation in Clinical Trials
Demonstrated superior outcomes in clinical trials at Harvard Medical School's Brigham and Women's Hospital and Mayo Clinic for pain and neuromuscular disorders.
Case study of digital therapeutics (JOGO) for post right MCA infarction, presented in December 2019.
Case study of utilization of digital therapeutics (JOGO) for post right MCA infarction.
A scientific publication in Nature Nov 2019 demonstrating the impact of EMG biofeedback on muscle activity in elderly adults.
A pilot randomized clinical trial published in Digital Health Jan 2023 showing the efficacy of JOGO's EMG biofeedback in chronic pain.
FDA Clearance and Reimbursement
JOGO's digital therapeutics are FDA-cleared and reimbursed by Medicare and commercial insurance for various conditions including cancer pain, migraines, pelvic pain, stroke recovery, and neuromuscular disorders.
Scientific Validation in Clinical Trials
Demonstrated superior outcomes in clinical trials at Harvard Medical School's Brigham and Women's Hospital and Mayo Clinic for pain and neuromuscular disorders.